Stock Events

Stock Events

Edesa Biotech 

$6.27
11
+$0.33+5.56% Today

Statistics

Day High
6.7
Day Low
5.56
52W High
20.32
52W Low
0.72
Volume
193,589
Avg. Volume
782,393
Mkt Cap
52.25M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7AugExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
-0.63
-0.5
-0.38
-0.25
Expected EPS
-0.625
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-14.37MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EDSA. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Moderna
MRNA
Mkt Cap19.8B
Moderna is involved in developing mRNA-based therapies, a field that overlaps with Edesa Biotech's focus on innovative treatments, making them direct competitors in the biotech space.
BioNTech
BNTX
Mkt Cap22.9B
BioNTech competes in the development of novel therapies, including mRNA vaccines and treatments, directly challenging Edesa Biotech's market.
Regeneron Pharmaceuticals
REGN
Mkt Cap64.18B
Regeneron Pharmaceuticals is a leader in biopharmaceuticals, focusing on immunology and inflammation, areas that Edesa Biotech is also targeting.
Gilead Sciences
GILD
Mkt Cap155.93B
Gilead Sciences is a biopharmaceutical company with a strong presence in antiviral drugs and treatments for inflammatory and respiratory diseases, competing with Edesa Biotech's research focus.
AMGEN
AMGN
Mkt Cap191.7B
Amgen is a biotech firm with a broad portfolio, including treatments for inflammatory diseases, which puts it in competition with Edesa Biotech's therapeutic areas.
Abbvie
ABBV
Mkt Cap402.35B
AbbVie operates in similar therapeutic areas as Edesa Biotech, including immunology and chronic diseases, making them competitors in the biopharmaceutical field.
Pfizer
PFE
Mkt Cap149.38B
Pfizer is a global pharmaceutical company with a wide range of products, including vaccines and biologics that compete with Edesa Biotech's developments.
Johnson & Johnson
JNJ
Mkt Cap579.83B
Johnson & Johnson, through its pharmaceutical division Janssen, develops treatments that overlap with Edesa Biotech's focus areas, particularly in immunology.
Novartis
NVS
Mkt Cap292.07B
Novartis is a global healthcare company with a strong emphasis on research and development in areas like dermatology and rheumatology, competing with Edesa Biotech.
Astrazeneca
AZN
Mkt Cap277.22B
AstraZeneca has a diverse biopharmaceutical portfolio, including treatments for respiratory and autoimmune diseases, making it a competitor to Edesa Biotech.

About

Edesa Biotech, Inc. is a biopharmaceutical firm focused on discovering, developing, and commercializing clinical-stage treatments for inflammatory and immune system disorders where current medical options are inadequate. The company's key pipeline assets include EB05, a monoclonal antibody undergoing a Phase 3 clinical trial for acute respiratory distress syndrome (ARDS) in COVID-19 patients, and EB01, a topical therapy in a Phase 2B clinical study addressing chronic allergic contact dermatitis. Furthermore, Edesa has a licensing collaboration with NovImmune SA to advance monoclonal antibodies specifically designed to target TLR4 and CXCL10. This company was established in 2015 and is based in Markham, Canada.
Show more...
CEO
Dr. Pardeep Nijhawan FRCPC, M.D.
Employees
16
Country
United States
ISIN
CA27966L3065

Listings

XNAS
US
EDSA
BOATS
BOATS
EDSA.BOATS

0 Comments

Share your thoughts

FAQ

What is Edesa Biotech stock price today?▼
The current price of EDSA is $6.27 USD — it has increased by +5.56% in the past 24 hours. Watch Edesa Biotech stock price performance more closely on the chart.
What is Edesa Biotech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Edesa Biotech stocks are traded under the ticker EDSA.
Is Edesa Biotech stock price growing?▼
EDSA stock has risen by +26.92% compared to the previous week, the month change is a -51.95% fall, over the last year Edesa Biotech has showed a +204.37% increase.
What is Edesa Biotech market cap?▼
Today Edesa Biotech has the market capitalization of 52.25M
When is the next Edesa Biotech earnings date?▼
Edesa Biotech is going to release the next earnings report on August 07, 2026.
What were Edesa Biotech earnings last quarter?▼
EDSA earnings for the last quarter are -0.49 USD per share, whereas the estimation was -0.26 USD resulting in a -88.46% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Edesa Biotech revenue for the last year?▼
Edesa Biotech revenue for the last year amounts to 0 USD.
What is Edesa Biotech net income for the last year?▼
EDSA net income for the last year is -14.37M USD.
How many employees does Edesa Biotech have?▼
As of June 16, 2026, the company has 16 employees.
In which sector is Edesa Biotech located?▼
Edesa Biotech operates in the Health & Wellness sector.
When did Edesa Biotech complete a stock split?▼
The last stock split for Edesa Biotech was on October 11, 2023 with a ratio of 1:7.
Where is Edesa Biotech headquartered?▼
Edesa Biotech is headquartered in Markham, United States.